Anifrolumab for treatment-resistant paediatric amyopathic dermatomyositis: report of two cases.

Saphnelo (anifrolumab-fnia) - AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/42752317

Andrea Taddio; Beatrice Lorenzon; Erica Valencic; Francesca Nicolardi; Gloria Fadanelli; Serena Pastore

Sep 18, 2026